Asuragen And Collaborators Report Results Using PCR-Only Technologies For The Comprehensive Molecular Assessment Of The Fragile X Gene
Jul 27th, 2010 | By buddy1 | Category: 35, Health & Wellness News, Mental HealthAsuragen, Inc. announced the results from two collaborative studies, one with the University of California Davis M.I.N.D. Institute and another with Rush University Medical Center, that demonstrate comprehensive molecular profiling of the Fragile X Mental Retardation (FMR1) gene using advanced PCR-based methods… Read The Full Article…Asuragen And Collaborators Report Results Using PCR-Only Technologies For The [...] Read more »



